methoxy polyethylene glycolepoetin beta sold brand name mircera longacting erythropoietin receptor activator cera used treatment anaemia associated chronic kidney first approved chemically modified erythropoiesisstimulating agent esacitation needed world health organizations list essential approved medical use european union switzerlandcitation needed united states methoxy polyethylene glycolepoetin beta made erythropoietin chemically linking nterminal amino group εamino group lysine present protein methoxy polyethylene glycol butanoic acidcitation needed average molecular weight approximately drug stimulates erythropoiesis interacting erythropoietin receptor progenitor cells bone reduced receptor binding activity compared esas retains vivo activity due extended serum halflifemedical citation needed vivo halflife around hours days compared darbepoetin alfa half life around hours half life three times naturally occurring erthropoietin bodymedical citation needed us federal appeals court ruled september mircera infringes patent held amgen inc court refused lift injunction entered fall barred roche selling mircera united however injunction since expired mircera available us market since mircera reportedly replace traditional erythropoietin drugs blood doping agent endurance sports drug appears fall section list substances officially prohibited competition competition france world antidoping july italian bicycle racer riccardo riccò disqualified tour de france reports urine sample tested positive previously public acknowledgment test new drug administered even developed yet tour de france testing done auspices french cycling federation french antidoping agency union cycliste httpsenwikipediaorgwikimethoxypolyethyleneglycolepoetinbeta